HopeStage
Back to all studies
CompletedNCT00716755

Lower antipsychotic doses and brain imaging in older adults with psychosis

About this titleRead the official source — NCT00716755
Medication studyAges 50+CanadaSchizophrenia
The study in practice

Understand this study

Who was this study for?

This study was for people with schizophrenia. Listed age limits: from 50 years. Other eligibility criteria applied.

Listed locations
TorontoSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateOctober 2009
Recruitment status
Completed
Enrollment listed in the registry
45
Sponsor
Centre for Addiction and Mental Health
Sponsor type
Hospital / academic medical center
Study type
Drug
Intervention type
Drug
Locations
Canada
Age range
Over 50 Years
Official registry ID
NCT00716755
Official title
Show the full official title

The Minimal Effective Dose of Antipsychotic Medication in Older Patients With Schizophrenia: a PET Study.

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Toronto

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Centre for Addiction and Mental Health, a hospital or academic medical center.

Did this study involve medication?

Yes. The study involved medication, including Risperidone/Olanzapine and PET scans.

Who was this study for?

This study was for people with schizophrenia. Listed age limits: from 50 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies